Butyric Acids
Research News and Information

Monday, November 23, 2009

Decursin inhibits retinal neovascularization via suppression of VEGFR-2 activation.

10 Sep 2009 PURPOSE: Pathologic angiogenesis in the retina leads to the catastrophic loss of vision. Retinopathy of prematurity (ROP), a vasoproliferative retinopathy, is a leading cause of blindness in children. We evaluated the inhibitory effect of decursin ... Read more...

Rabies virus glycoprotein expression in Drosophila S2 cells. I: design of expression/selection vectors, subpopulations selection and influence of sodium butyrate and culture medium on protein expression.

13 Jul 2009 The cDNA encoding the rabies virus glycoprotein (RVGP) gene was cloned in expression plasmids under the control of the inductive metallothionein promoter. They were designed in order to bear or not a secretion signal (i) and a cDNA coding for the ... Read more...

Synthesis of dideoxymycobactin antigens presented by CD1a reveals T cell fine specificity for natural lipopeptide structures.

13 Jul 2009 Mycobacterium tuberculosis survival in cells requires mycobactin siderophores. Recently, the search for lipid antigens presented by the CD1a antigen-presenting protein led to the discovery of a mycobactin-like compound, dideoxymycobactin (DDM). Here ... Read more...

Latest indexed articles for 'Butyric Acids'

These are the very latest articles for this heading:

• Decursin inhibits retinal neovascularization via suppression of VEGFR-2 activation. 10 Sep 2009
• Rabies virus glycoprotein expression in Drosophila S2 cells. I: design of expression/selection vectors, subpopulations selection and influence of sodium butyrate and culture medium on protein expression. 13 Jul 2009
• Synthesis of dideoxymycobactin antigens presented by CD1a reveals T cell fine specificity for natural lipopeptide structures. 13 Jul 2009
• Studies on the pharmacokinetics and metabolism of a gamma-secretase inhibitor BMS-299897, and exploratory investigation of CYP enzyme induction. 29 Jun 2009
• The analgesic effect of decursinol. 24 Jun 2009
• Transaminase-catalyzed asymmetric synthesis of L-2-aminobutyric acid from achiral reactants. 21 Jun 2009
• Decursin inhibits VEGF-mediated inner blood-retinal barrier breakdown by suppression of VEGFR-2 activation. 15 Jun 2009
• Structural and theoretical studies of [6-bromo-1-(4-fluorophenylmethyl)-4(1H)-quinolinon-3-yl)]-4-hydroxy-2-oxo-3-butenoïc acid as HIV-1 integrase inhibitor. 12 Jun 2009
• Highly enantioselective organocatalytic Michael addition of nitroalkanes to 4-oxo-enoates. 8 Jun 2009
• Arbaclofen placarbil, a novel R-baclofen prodrug: improved absorption, distribution, metabolism, and elimination properties compared with R-baclofen. 3 Jun 2009
• [Design and synthesis of peroxisome proliferator-activated receptor (PPAR) delta agonists and its implication to the driving force to elicit PPAR delta selectivity] 30 May 2009
• Peroxisome proliferator-activated receptor (PPAR)-gamma positively controls and PPARalpha negatively controls cyclooxygenase-2 expression in rat brain astrocytes through a convergence on PPARbeta/delta via mutual control of PPAR expression levels. 27 May 2009
• HDAC2 negatively regulates memory formation and synaptic plasticity. 5 May 2009
• Synthesis of gamma-nitro aliphatic methyl esters via Michael additions promoted by microwave irradiation. 19 Apr 2009
• Central administration of palmitoylethanolamide reduces hyperalgesia in mice via inhibition of NF-kappaB nuclear signalling in dorsal root ganglia. 18 Apr 2009
• Glutamine inhibits ammonia-induced accumulation of cGMP in rat striatum limiting arginine supply for NO synthesis. 16 Apr 2009
• Decursin and decursinol inhibit VEGF-induced angiogenesis by blocking the activation of extracellular signal-regulated kinase and c-Jun N-terminal kinase. Apr 2009
• [Studies on chemical constituents from roots of Peucedanum praeruptorum III] 30 Mar 2009
• Poly-3-hydroxy butyric acid interaction with the transgenic flax fibers: FT-IR and Raman spectra of the composite extracted from a GM flax. 3 Mar 2009
• A novel (S)-(+)-decursin derivative, (S)-(+)-3-(3,4-dihydroxy-phenyl)-acrylic acid 2,2-dimethyl-8-oxo-3,4-dihydro-2H,8H-pyrano[3,2-g]chromen-3-yl-ester, inhibits ovalbumin-induced lung inflammation in a mouse model of asthma. 27 Feb 2009

See a longer list of these articles.

Technical information about 'Butyric Acids'

Definition: 4-carbon acids, salts, and derivatives of BUTYRIC ACID.

Registry Number: 0

Descriptor UI: D002088

Alternative terms: Butyric Acids; Acids, Butyric; Butanoic Acids; Acids, Butanoic;

Allowable Qualifiers: administration & dosage; adverse effects; analysis; antagonists & inhibitors; blood; cerebrospinal fluid; chemical synthesis; classification; diagnostic use; economics; history; immunology; isolation & purification; metabolism; pharmacokinetics; pharmacology; poisoning; radiation effects; standards; supply & distribution; therapeutic use; toxicity; urine; chemistry; contraindications; agonists;

Tree Number: D02.241.081.160; D10.251.400.241;

History Note: 91(75); was see under BUTYRATES 1975-90

Technical Notes: BUTYRIC ACID is also available